Biocon Biologics Successfully Integrates Acquired Biosimilars Business Across 120 Countries

Biocon Biologics, a unique, fully integrated, global biosimilars company with a rich portfolio of insulins and monoclonal antibodies, has successfully conc...

 December 19, 2023 | News

Australian Neuren Phase 2 Trial Reveals Significant Improvements in Phelan-McDermid Syndrome

Highlights:  Significant improvement was assessed by both clinicians and caregivers across multiple efficacy measures   Improvements were con...

 December 19, 2023 | News

Advancing Lung Cancer Treatment: Insights from Professor Benjamin Solomon on the ALINA Study and the Future of ALK-Positive NSCLC

In an exclusive BioPharma APAC interview, Professor Benjamin Solomon, a distinguished Medical Oncologist at the Peter MacCallum Cancer Centre, Australia, a...

 December 18, 2023 | News

MGI Australia Introduces Innovative CEC with DCS Lab Products for Advanced DNA, Cell, and Spatial-omics Technology

MGI Australia, a subsidiary of MGI Tech Co. Ltd. (MGI), a global leader in life science technology, is delighted to announce a substantial expans...

 December 15, 2023 | News

Atmo Biosciences achieves patient recruitment target for dysmotility pivotal clinical study

Atmo Biosciences, a company commercializing the world’s first ingestible gas-sensing capsule that provides insights into gut health and microbiome fu...

 December 14, 2023 | News

Imagion Reports Positive Results in Phase I Study for MagSense® HER2 Imaging Agent

Imagion Biosystems Limited (ASX: IBX) recently announced positive results following completion of the IBI10103 phase I clinical trial evaluating the safety...

 December 14, 2023 | News

Clover Initiates Phase Ⅰ Clinical Trial for RSV Vaccine Candidate

Clover Biopharmaceuticals, Ltd.  a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save li...

 December 13, 2023 | News

First Patient Dosed in U.S. Access Program for Telix's TLX250-CDx Kidney Cancer Imaging

The patient was dosed at ARA Diagnostic Imaging at Austin Radiological Association in Austin (TX, U.S.) following U.S. Food and Drug Administrati...

 December 12, 2023 | News

Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics,  announced its progression to the second st...

 December 12, 2023 | News

IonOpticks and Newomics Collaborate to Boost Aurora Series Columns Compatibility with Agilent Mass Spectrometers

  IonOpticks is renowned for its class-leading chromatography solutions, particularly the Aurora Series, which are celebrated for their precision, ef...

 December 07, 2023 | News

ObvioHealth and Chemist Warehouse Partner to Power Clinical Trial Efficiency in Australia

The partnership gives sponsors easier access to a wider pool of participants by driving awareness about trials to Chemist Warehouse's customers in Australi...

 December 06, 2023 | News

Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort

Cohort 3 of the theranostic SECuRE trial investigating 64Cu/67Cu-SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has enrolled a...

 November 30, 2023 | News

Merz Therapeutics Receives TGA Approval for XEOMIN® in Australia

This marks a significant milestone as XEOMIN® is the first approved neurotoxin for the treatment of this condition in the Australian market. Addit...

 November 23, 2023 | News

Prospection AI Launches Single-source Patient-centric Platform in Australia to Boost Drug Commercialization

-Prospection—the pioneer of patient-centric intelligence—today announced the availability of Prospection AI, its self-service patient-cent...

 November 21, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in